Cross talk between cancer and immune cells: exploring complex dynamics in a microfluidic environment
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
The reconstitution of a complex microenvironment on microfluidic chips is one of the cornerstones to demonstrate the improved flexibility of these devices with respect to macroscale in vitro approaches. In this work, we realised an on-chip model to investigate the interactions between cancer and immune system. To this end, we exploited mice deficient (Knock Out, KO) for interferon regulatory factor 8 (IRF-8), a transcription factor essential for the induction of competent immune responses, to investigate how IRF-8 gene expression contributes to regulate immune and melanoma cells crosstalk. In vivo, IRF-8 KO mice are highly permissive to B16 melanoma growth due to failure of immune cells to properly exert immunosurveillance. B16 cells and immune cells isolated from the spleen of wild type (WT) and IRF-8 KO mice were co-cultured for one week in a PDMS platform and monitored by fluorescence microscopy and time-lapse recordings. We observed that WT spleen cells migrated through microchannels connecting the culturing chambers towards B16 cells and tightly interacted with tumor cells, forming clusters of activation. In contrast, IRF-8 KO immune cells poorly interacted with melanoma cells. In parallel, B16 cells were more attracted towards microchannels, acquiring a more invasive behaviour in the presence of IRF-8 KO spleen cells, with respect to WT cells. Our results strongly confirm the in vivo observations and highlight the value of on-chip co-culture systems as a useful in vitro…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Specifically, they showed that immune spleen cells lacking IRF-8 do not migrate towards cancer cells, nor interact with them as efficiently as wild type immune cells[48–50], suggesting a mechanism to explain why IRF-8 knock-out cells fail to exert proper immune-surveillance leading to a heavier metastatic burden.”
From Microfluidics: A New Tool for Modeling Cancer–Immune Interactions (2016) · cites this paper as [49]
In the citing paper
“To the best of our knowledge, only a limited number of recent studies have employed microfluidics to investigate immune-cancer cell interactions[18, 48–52], possibly because microfluidic models are not yet widely available to cancer researchers.”
From Microfluidics: A New Tool for Modeling Cancer–Immune Interactions (2016) · cites this paper as [49]
Citations
Cites
1 retracted
Jazirehi, A. R., Baritaki, S., Koya, R. C., Bonavida, B., & Economou, J. S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1296 · Cited by 32
RetractedThe origins and the future of microfluidics
Whitesides, G. M. (2006) · Nature · doi:10.1038/nature05058 · Cited by 9,687
Cancer immunoediting: from immunosurveillance to tumor escape
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology · doi:10.1038/ni1102-991 · Cited by 5,393
In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro
Liang, C.-C., Park, A. Y., & Guan, J.-L. (2007) · Nature Protocols · doi:10.1038/nprot.2007.30 · Cited by 4,696
Isolation of rare circulating tumour cells in cancer patients by microchip technology
Nagrath, S., Sequist, L. V., Maheswaran, S., Bell, D. W., Irimia, D., Ulkus, L., Smith, M. R., Kwak, E. L., Digumarthy, S., Muzikansky, A., et al. (2007) · Nature · doi:10.1038/nature06385 · Cited by 3,559
The control of human mesenchymal cell differentiation using nanoscale symmetry and disorder
Dalby, M. J., Gadegaard, N., Tare, R., Andar, A., Riehle, M. O., Herzyk, P., Wilkinson, C. D. W., & Oreffo, R. O. C. (2007) · Nature Materials · doi:10.1038/nmat2013 · Cited by 2,416
Soft lithography for micro- and nanoscale patterning
Qin, D., Xia, Y., & Whitesides, G. M. (2010) · Nature Protocols · doi:10.1038/nprot.2009.234 · Cited by 2,334
El-Ali, J., Sorger, P. K., & Jensen, K. F. (2006) · Nature · doi:10.1038/nature05063 · Cited by 2,102
Diagnosing the decline in pharmaceutical R&D efficiency
Scannell, J. W., Blanckley, A., Boldon, H., & Warrington, B. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3681 · Cited by 1,981
Geometric cues for directing the differentiation of mesenchymal stem cells
Kilian, K. A., Bugarija, B., Lahn, B. T., & Mrksich, M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903269107 · Cited by 1,841
Research works printed but not linked: 8
- Khetani, 2008, Nat Biotechnol, 26
- Huh, 2010, Science, 328
- Weibel, 2007, Nature Reviews, 5, 210
- Prager-Khoutorsky, 2011, Nature Cell Biology, 13
- Ghiringhelli, Cancer Immunol Immunother, 2006
- Shahshahan, 2011, Am J Cancer Res, 1, 913
- Poste, 1982, Cancer Res, 42, 2770
- Mattei, 2009, Eur. J. Immunol., 39, S621, 10.1002/eji.200939233 · DOI · Paper page
Cited by
Organs-on-chips at the frontiers of drug discovery
Esch, E. W., Bahinski, A., & Huh, D. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4539 · Cited by 1,185
Functional and Biomimetic Materials for Engineering of the Three-Dimensional Cell Microenvironment
Huang, G., Li, F., Zhao, X., Ma, Y., Li, Y., Lin, M., Jin, G., Lu, T. J., Genin, G. M., & Xu, F. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00094 · Cited by 825
Ahmed, N., & Stenvers, K. L. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00256 · Cited by 482
“These studies, even though not directly related to CAFs in the ascites of ovarian cancer patients implicate CAFs as an important modulator of promoting ovarian tumor growth.”
BackgroundMethodInfluentialChemotherapy-induced antitumor immunity requires formyl peptide receptor 1
Vacchelli, E., Ma, Y., Baracco, E. E., Sistigu, A., Enot, D. P., Pietrocola, F., Yang, H., Adjemian, S., Chaba, K., Semeraro, M., et al. (2015) · Science · doi:10.1126/science.aad0779 · Cited by 452
Self-citationRecent advances in microfluidic technologies for cell-to-cell interaction studies
Rothbauer, M., Zirath, H., & Ertl, P. (2018) · Lab on a Chip · doi:10.1039/c7lc00815e · Cited by 277
Metadata
- Authors
- Businaro, L., De Ninno, A., Schiavoni, G., Lucarini, V., Ciasca, G., Gerardino, A., Belardelli, F., Gabriele, L., & Mattei, F.
- Affiliations
- National Research Council (IT)
- Istituto Superiore di Sanità (IT)
- Corresponding author
- Businaro, Luca
- Mattei, Fabrizio
- ORCID
- Venue
- Lab Chip
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2013
- Volume
- 13
- Issue
- 2
- Pages
- 229-239
- ISSN
- 1473-0189 (ISSN-L)
- 1473-0197
- OpenAlex
- W2033651938
- Cited by
- 162
- References
- 52
- Citations by year
- 2026: 8 · 2025: 8 · 2024: 14 · 2023: 11 · 2022: 17 · 2021: 18 · 2020: 11 · 2019: 14 · 2018: 18 · 2017: 12 · 2016: 10 · 2015: 7 · 2014: 4 · 2013: 8
- FWCI
- 3.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Lab on a Chip (publishedVersion)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Bio-sensing Technologies
- Keywords
- IRF8, B16 melanoma, tumor surveillance, microfluidics, PDMS microchannel, leukocyte migration, tumor invasion, splenocytes, anti-tumor therapy
- MeSH terms
- Interferon Regulatory Factor-8, Animals, Cell Communication, Cell Movement, Cells, Cultured, Flow Cytometry, Melanoma, Mice, Inbred C57BL, Microscopy, Fluorescence, Spleen, Stress, Physiological, Mice, Knockout, Coculture Techniques, Microfluidic Analytical Techniques, Interferon Regulatory Factors, Mice, Time-Lapse Imaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cross talk between cancer and immune cells: exploring complex dynamics in a microfluidic environment. https://app.cochat.ai/papers/10.1039/c2lc40887b
- The paper
- Businaro, L., De Ninno, A., Schiavoni, G., Lucarini, V., Ciasca, G., Gerardino, A., Belardelli, F., Gabriele, L., & Mattei, F. (2013). Cross talk between cancer and immune cells: exploring complex dynamics in a microfluidic environment. Lab Chip. https://doi.org/10.1039/c2lc40887b
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.